[ Double - blind placebo - controlled study of the effectiveness and tolerability of 10 and 30 mg <font color="blue">ketorolac_1</font> <font color="blue">tromethamine_1</font> <font color="blue">suppositories_1</font> <font color="blue">in_1</font> <font color="blue">post_3</font> <font color="blue">-_3</font> <font color="blue">cholecystectomy_3</font> <font color="blue">pain_3</font> <font color="blue">]_3</font> . 
<br>
<br> OBJECTIVE To evaluate the efficacy and tolerability of ketorolac tromethamine 10 mg and 30 mg suppositories in comparison to placebo , after single dose administration in <font color="blue">patients_3</font> <font color="blue">suffering_3</font> <font color="blue">from_3</font> <font color="blue">post_3</font> <font color="blue">-_3</font> <font color="blue">operative_3</font> <font color="blue">pain_3</font> <font color="blue">after_3</font> <font color="blue">cholecystectomy_3</font> <font color="blue">._3</font> 
<br> DESIGN Double - blind , randomized , controlled study . 
<br> SETTING Anaesthesia Service . 
<br> PATIENTS <font color="blue">99_5</font> <font color="blue">patients_5</font> <font color="blue">with_5</font> <font color="blue">severe_5</font> <font color="blue">pain_5</font> <font color="blue">following_5</font> <font color="blue">surgery_5</font> <font color="blue">._5</font> 
<br> INTERVENTIONS Cholecystectomy . 
<br> MEASUREMENTS AND MAIN RESULTS The analgesia activity of ketorolac tromethamine 10 mg and 30 mg suppositories were evaluated after single dose administration by assessing pain intensity and pain relief using a 4 point scale ( VRS ) . At the end of the treatment period overall assessment of safety and efficacy were recorded by physician and patient . The results show that in both active groups after 30 ' and until 4 hours , pain intensity decreased significantly with respect to the baseline . However a statistically significant difference between groups of p < 0.02 , p < 0.01 and p < 0.05 was found in favour of the 30 mg dose respectively at 30 ' , 6 and 8 hours after administration . All the patients treated with placebo suppositories required another rescue analgesic drug and withdrew from the trial . Three patients complained adverse events not related to treatment : two on placebo and one on ketorolac 10 mg . The systemic and local tolerability of the drug was good . 
<br> CONCLUSIONS This study shows that ketorolac 30 mg suppositories are effective <font color="blue">in_1</font> <font color="blue">clinical_1</font> <font color="blue">conditions_1</font> <font color="blue">,_1</font> <font color="blue">such_1</font> <font color="blue">as_1</font> <font color="blue">after_2</font> <font color="blue">surgery_2</font> <font color="blue">,_2</font> <font color="blue">in_1</font> <font color="blue">which_1</font> <font color="blue">pain_1</font> <font color="blue">control_1</font> <font color="blue">must_1</font> <font color="blue">be_1</font> <font color="blue">achieved_1</font> <font color="blue">within_1</font> <font color="blue">the_1</font> <font color="blue">shortest_1</font> <font color="blue">time_1</font> <font color="blue">interval_1</font> <font color="blue">and_1</font> <font color="blue">maintained_1</font> <font color="blue">or_1</font> <font color="blue">improved_1</font> <font color="blue">by_1</font> <font color="blue">means_1</font> <font color="blue">of_1</font> <font color="blue">a_1</font> <font color="blue">single_1</font> <font color="blue">route_1</font> <font color="blue">of_1</font> <font color="blue">administration_1</font> <font color="blue">._1</font>